PL3466435T3 - Środek poprawiający funkcjonowanie mózgu - Google Patents

Środek poprawiający funkcjonowanie mózgu

Info

Publication number
PL3466435T3
PL3466435T3 PL17806709.6T PL17806709T PL3466435T3 PL 3466435 T3 PL3466435 T3 PL 3466435T3 PL 17806709 T PL17806709 T PL 17806709T PL 3466435 T3 PL3466435 T3 PL 3466435T3
Authority
PL
Poland
Prior art keywords
agent
brain function
improves brain
improves
function
Prior art date
Application number
PL17806709.6T
Other languages
English (en)
Inventor
Youdai KOBAYASHI
Tetsuya Kuhara
Kanetada Shimizu
Takumi Sato
Original Assignee
Morinaga Milk Industry Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Morinaga Milk Industry Co., Ltd. filed Critical Morinaga Milk Industry Co., Ltd.
Publication of PL3466435T3 publication Critical patent/PL3466435T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/322—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the nervous system or on mental function
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/20—Natural extracts
    • A23V2250/206—Bacterial extracts
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/519—Breve
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Polymers & Plastics (AREA)
  • Psychiatry (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Nutrition Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Physiology (AREA)
  • Animal Husbandry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PL17806709.6T 2016-05-31 2017-05-31 Środek poprawiający funkcjonowanie mózgu PL3466435T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2016108944 2016-05-31
PCT/JP2017/020173 WO2017209156A1 (ja) 2016-05-31 2017-05-31 脳機能改善剤

Publications (1)

Publication Number Publication Date
PL3466435T3 true PL3466435T3 (pl) 2023-12-27

Family

ID=60477549

Family Applications (1)

Application Number Title Priority Date Filing Date
PL17806709.6T PL3466435T3 (pl) 2016-05-31 2017-05-31 Środek poprawiający funkcjonowanie mózgu

Country Status (11)

Country Link
US (2) US10980849B2 (pl)
EP (2) EP3466435B1 (pl)
JP (4) JP6853821B2 (pl)
KR (3) KR102844378B1 (pl)
CN (3) CN109789174B (pl)
AU (2) AU2017275210B2 (pl)
ES (1) ES2960082T3 (pl)
HU (1) HUE063858T2 (pl)
PL (1) PL3466435T3 (pl)
TW (2) TWI784953B (pl)
WO (1) WO2017209156A1 (pl)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201821093A (zh) 2016-07-13 2018-06-16 英商４Ｄ製藥有限公司 包含細菌菌株之組合物
JPWO2019188943A1 (ja) * 2018-03-26 2021-03-25 森永乳業株式会社 脳血流低下の予防及び／又は改善用組成物
JP7285096B2 (ja) * 2018-03-28 2023-06-01 森永乳業株式会社 ストレス緩和用組成物並びに該ストレス緩和用組成物を用いた医薬品組成物及び飲食品組成物
EP3777869B1 (en) * 2018-03-28 2024-07-31 Morinaga Milk Industry Co., Ltd. Sleep-promoting composition, and medicinal composition and food and beverage composition using said sleep-promoting composition
TW202023590A (zh) 2018-08-17 2020-07-01 英商4D製藥研究有限公司 包含細菌菌株之組合物
CN108949640B (zh) * 2018-08-22 2020-08-04 江南大学 短双歧杆菌ccfm1025、其发酵食品及其应用
CA3126331A1 (en) * 2019-01-09 2020-07-16 Ken-ichi YAMADA Pharmaceutical composition for treatment of dementia and cerebrovascular disorders
JP7299744B2 (ja) * 2019-04-26 2023-06-28 森永乳業株式会社 血中尿酸値低減用組成物、及び高尿酸血症予防又は改善用組成物、並びに、該組成物を用いた医薬品組成物及び飲食品組成物
JP6739603B1 (ja) * 2019-07-24 2020-08-12 雪印メグミルク株式会社 記憶・学習能維持および／または向上用組成物及び組成物を含む食品、医薬品、飼料
JP6739602B1 (ja) * 2019-07-24 2020-08-12 雪印メグミルク株式会社 記憶・学習能維持および／または向上用組成物及び組成物を含む食品、医薬品、飼料
CN110787190B (zh) * 2019-12-17 2020-06-16 杨波 一种具有抗衰老作用的复合益生菌组合物及其制法和应用
JP2023511678A (ja) * 2020-01-24 2023-03-22 森永乳業株式会社 神経突起伸長改善用組成物
JP2021020885A (ja) * 2020-03-09 2021-02-18 雪印メグミルク株式会社 記憶・学習能維持および／または向上用組成物及び組成物を含む食品、医薬品、飼料
JP2021153446A (ja) * 2020-03-26 2021-10-07 森永乳業株式会社 抗ストレス用組成物
US20230218686A1 (en) * 2020-06-18 2023-07-13 Morinaga Milk Industry Co., Ltd. Cognitive Function Improving Agent, Cognitive Function Maintaining Agent, Hippocampus Function Improving Agent, and Hippocampus Function Maintaining Agent
CN113215034B (zh) * 2021-04-30 2022-08-02 江南大学 一株能够缓解阿尔兹海默症并增加粪便乙酸含量的短双歧杆菌及其应用
TWI794800B (zh) * 2021-04-30 2023-03-01 國立中興大學 克弗爾胜肽用於改善或治療憂鬱行為及其相關病症之用途
JP2023063132A (ja) * 2021-10-22 2023-05-09 森永乳業株式会社 脳萎縮抑制剤、脳萎縮の抑制方法、培養物、培養物の使用、飲食品、脳萎縮抑制用食品、脳萎縮抑制用サプリメント、及び脳萎縮抑制用医薬
WO2024209522A1 (en) * 2023-04-03 2024-10-10 Morinaga Milk Industry Co., Ltd. Bifidobacterium for reducing perilipin 4 expression
CN117106672B (zh) * 2023-10-16 2024-01-30 微康益生菌(苏州)股份有限公司 一种改善衰老相关的认知障碍的短双歧杆菌及其应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1974743A1 (en) * 2007-03-28 2008-10-01 Nestec S.A. Probiotics to Improve Gut Microbiota
WO2008153377A1 (en) * 2007-06-15 2008-12-18 N.V. Nutricia Nutrition with non-viable bifidobacterium and non-digestible oligosaccharide
WO2009043856A2 (en) * 2007-10-01 2009-04-09 University College Cork, National University Of Ireland, Cork Modulation of tissue fatty acid composition of a host by human gut bacteria
EP2110028A1 (en) 2008-04-15 2009-10-21 Nestec S.A. Bifidobacterium longum and hippocampal BDNF expression
ES2647922T3 (es) * 2009-09-17 2017-12-27 Morinaga Milk Industry Co., Ltd. Agente anti-obesidad, alimento o bebida anti-obesidad, agente que mejora la tolerancia a la glucosa, y alimento o bebida para mejorar la tolerancia a la glucosa
KR101148958B1 (ko) * 2009-12-30 2012-05-22 경희대학교 산학협력단 대두류의 소야사포닌 추출물 또는 그로부터 분리된 화합물을 포함하는 기억력 감퇴 또는 뇌손상 개선제
JP5615285B2 (ja) * 2010-03-18 2014-10-29 森永乳業株式会社 貧血の予防又は治療用組成物
CN108741083A (zh) * 2010-12-31 2018-11-06 雅培制药有限公司 促进有益细菌生长的中性人乳寡糖
SG191798A1 (en) * 2010-12-31 2013-08-30 Abbott Lab Synbiotic combination of probiotic and human milk oligosaccharides to promote growth of beneficial microbiota
JP2014009214A (ja) 2012-07-02 2014-01-20 Lion Corp アミロイド前駆タンパク質発現抑制剤
WO2014027864A1 (ko) * 2012-08-16 2014-02-20 경희대학교 산학협력단 노화 및 치매의 예방 및/또는 치료 활성을 갖는 유산균
IN2015DN03862A (pl) * 2012-11-02 2015-10-02 Nutricia Nv
JP6291158B2 (ja) 2012-11-21 2018-03-14 サントリーホールディングス株式会社 抗認知症および学習記憶改善剤
JP6139217B2 (ja) * 2013-03-29 2017-05-31 森永乳業株式会社 Ｄ−アミノ酸の製造方法
CA2964971C (en) * 2014-10-28 2023-04-11 Medlab Ip Pty Ltd Treatment for depression and depressive disorders

Also Published As

Publication number Publication date
KR102844378B1 (ko) 2025-08-07
KR20220020987A (ko) 2022-02-21
KR20240052882A (ko) 2024-04-23
JP7532468B2 (ja) 2024-08-13
ES2960082T3 (es) 2024-02-29
US20190083549A1 (en) 2019-03-21
KR20190009795A (ko) 2019-01-29
JP6853821B2 (ja) 2021-03-31
CN109789174A (zh) 2019-05-21
US10980849B2 (en) 2021-04-20
US20210196768A1 (en) 2021-07-01
TW201808313A (zh) 2018-03-16
EP3466435B1 (en) 2023-08-16
JP2021091732A (ja) 2021-06-17
AU2017275210B2 (en) 2020-09-10
CN116196340A (zh) 2023-06-02
AU2020277138B2 (en) 2024-02-29
EP3466435A4 (en) 2020-01-08
EP4268616A3 (en) 2023-12-06
TW202247848A (zh) 2022-12-16
KR102357136B1 (ko) 2022-01-27
HUE063858T2 (hu) 2024-02-28
JP2022176361A (ja) 2022-11-25
KR102692748B1 (ko) 2024-08-06
TWI784953B (zh) 2022-12-01
EP3466435A1 (en) 2019-04-10
WO2017209156A1 (ja) 2017-12-07
JP2024153837A (ja) 2024-10-29
CN116059257A (zh) 2023-05-05
EP3466435C0 (en) 2023-08-16
TWI837785B (zh) 2024-04-01
JPWO2017209156A1 (ja) 2019-01-17
AU2020277138A1 (en) 2020-12-24
AU2017275210A1 (en) 2019-01-24
CN109789174B (zh) 2022-08-12
JP7157196B2 (ja) 2022-10-19
EP4268616A2 (en) 2023-11-01

Similar Documents

Publication Publication Date Title
PL3466435T3 (pl) Środek poprawiający funkcjonowanie mózgu
EP3482279A4 (en) VEHICLE INTERIOR ELEMENT
EP3426163A4 (en) Retractor
EP3332840C0 (en) HARNESS
CL2016001960S1 (es) Automovil
EP3505434A4 (en) VEHICLE
CL2016002006S1 (es) Automovil
CL2016002093S1 (es) Automovil
CL2016002796S1 (es) Automóvil
CL2017000733S1 (es) Automóvil
CL2016002472S1 (es) Automóvil
UA35043S (uk) Автомобіль
FR3049869B1 (fr) Harnais
EP3505433A4 (en) VEHICLE
EP3449930C0 (en) SYNAPSE TRAINING AGENT
EP3450289A4 (en) VEHICLE
EP3604098A4 (en) VEHICLE
CL2017001529S1 (es) Automóvil
EP3705388A4 (en) VEHICLE
CL2016002622S1 (es) Automovil
EP3628578A4 (en) VEHICLE
EP3308781A4 (en) BLOOD PRESSURE CENTER
DK3216503T3 (da) Rutsjebanekøretøj
EP3604099A4 (en) VEHICLE
EP3604847A4 (en) VEHICLE